DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • Netherlands
  • /
  • Materials
Author Program NEWCreate Narrative
CRBN logo

Corbion N.V. Stock Price

ENXTAM:CRBN Community·€1.2b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 32 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

CRBN Share Price Performance

€0
-16.91 (-100.00%)
​
€26.00
Fair Value
€0
-16.91 (-100.00%)
​
Price €0
Mon, 29 Jun 26
Fair Value€26.00
Share Pricen/a

CRBN Community Narratives

AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value €26 21.3% undervalued intrinsic discount

Global Sustainable Demand And PLA Breakthroughs Will Transform Markets

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value €19.6 4.4% overvalued intrinsic discount

Rising Regulatory And Feedstock Costs Will Erode Future Margins

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value €24.03 14.9% undervalued intrinsic discount

Thai Ramp-Up And Chinese Approvals Will Boost Efficiency

0users have liked this narrative
0users have commented on this narrative
16users have followed this narrative
CRBN logo
Corbion
21.3% undervalued intrinsic discount

Global Sustainable Demand And PLA Breakthroughs Will Transform Markets

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 29 Jun
Read Narrative
CRBN logo
Corbion
14.9% undervalued intrinsic discount

Thai Ramp-Up And Chinese Approvals Will Boost Efficiency

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 22 Apr
Read Narrative
CRBN logo
Corbion
4.4% overvalued intrinsic discount

Rising Regulatory And Feedstock Costs Will Erode Future Margins

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 8 Apr
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystHighTarget
CRBN logo

CRBN: Special Dividend And Affirmed Guidance Will Support Future Rerating

Fair Value: €26 21.3% undervalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
CRBN logo

CRBN: Special Dividend And Execution On Margins Will Support Upside Potential

Fair Value: €24.03 14.9% undervalued intrinsic discount
16 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystLowTarget
CRBN logo

CRBN: Raised Fair Value And Barclays Downgrade Will Shape Risk Balance

Fair Value: €19.6 4.4% overvalued intrinsic discount
2 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Good value with adequate balance sheet.

2 Risks
2 Rewards
View Full Analysis

Corbion N.V. Key Details

€1.3b

Revenue

€939.0m

Cost of Revenue

€313.9m

Gross Profit

€251.7m

Other Expenses

€62.2m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
Oct 28, 2026
1.08
25.05%
4.96%
61.7%
View Full Analysis

About CRBN

Founded
1903
Employees
2363
CEO
Olivier Rigaud
WebsiteView website
www.corbion.com

Corbion N.V. provides lactic acid and derivatives, food preservation solutions, functional ingredient systems, and algae-derived nutritional ingredients in the Netherlands, the United States, Asia, rest of Americas, the rest of Europe, the Middle East, and Africa. It operates in two segments, Functional Ingredients & Solutions, and Health & Nutrition. The company offers antioxidants, fermentation and preservation ingredients, flavors, fortification, functional blends, and lactic acid lactates and derivatives; AlgaPrime DHA, an omega-3 sourcing product; AlgaVia which develops foods and beverages with reduced saturated fat content; CALFEED, a dry lactic acid source to boost feed intake for swine or poultry; LAFEED that helps feed intake and digestive health; LAFEED Powder that acts as a preservative and acidulate; PURAC DW, provides an acidifier, preservative, and antimicrobial in teat-dip applications for animals; PURAC Pet food; PURASOLV; and PURASOLV EL. It also provides PURASORB polymers for medical and pharmaceutical industries; PURASOLV solvents; PURALACT B3 for resin and coating performance; personal care products, such as ESTERLAC Emulsifiers and Surfactants, GLUCONAL ZN, PURAC BF/P41, PURAC HiPure 90, PURAC UltraPure, PURACAL PP/USP, PURAMEX ZN, PURASAL MOISTXS, PURASAL NH/COS, PURASAL S/HQ60, and PURASOLV EL; and GLUCONAL, PURAC PF, PURACAL, PURAMEX, and PURASAL S/PF. In addition, the company offers food solutions, including acidification, color retention, decontamination, food safety and preservation, freshness and shelf life, health and nutrition, strengthening conditioning and texturizing, and taste and texture; PURASORB R&D; biochemical specialties solutions comprising solvency, antimicrobial, moisturization, and pharma; and Algae ingredients solutions. The company was formerly known as CSM N.V. and changed its name to Corbion N.V. in October 2013. Corbion N.V. was founded in 1903 and is headquartered in Amsterdam, the Netherlands.

Recent CRBN News & Updates

Analysis Article • Aug 04

Revenue Beat: Corbion N.V. Beat Analyst Estimates By 6.3%

It's been a good week for Corbion N.V. ( AMS:CRBN ) shareholders, because the company has just released its latest...

Recent updates

No updates

Corbion N.V. Competitors

APAM logo

Aperam

Symbol: ENXTAM:APAM
Market cap: €3.4b
AMG logo

AMG Critical Materials

Symbol: ENXTAM:AMG
Market cap: €1.2b
OCI logo

OCI

Symbol: ENXTAM:OCI
Market cap: €858.2m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide